TRANSCODE THERAPEUTICS INC

0 institutions still hold TRANSCODE THERAPEUTICS INC as of —. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.

CUSIP 89357L501·0 13F holders

Market cap

—

▲ 4.4%

vs prior quarter

13F value held

$38.0B

76.0% inst. owned

of float

Holders

+2 QoQ

filers reporting

Activity

+42 / −57

+996 added · −774 reduced

this quarter

Concentration

—

top holder share

AI Holders Summary · —

0 institutions reported RNAZ in —. Top-holder concentration data is loading. +2 net new institutions vs prior quarter — accumulation reading.